Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes

被引:17
|
作者
Rodriguez-Hernandez, Heriberto [1 ,2 ]
Gonzalez, Jose L.
Marquez-Ramirez, Maria Dolores [3 ]
Flores-Hernandez, Marissa [3 ]
Rodriguez-Moran, Martha [1 ,2 ]
Guerrero-Romero, Fernando [1 ,2 ]
机构
[1] Mexican Social Secur Inst, Biomed Res Unit, Durango, Mexico
[2] Res Grp Diabet & Chron Illnesses, Durango, Mexico
[3] Gen Hosp, Mexican Social Secur Inst, Dept Radiol & Ultrasonog, Durango, Mexico
关键词
alanine aminotransferase; aspartate aminotransferase; nonalcoholic fatty liver disease; nonalcoholic steatohepatitis; obesity; risk factors; steatosis; women;
D O I
10.1097/MEG.0b013e3282f448af
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objective The objective of this study is to determine the association between risk factors and nonalcoholic fatty liver disease (NAFLD), and to establish the relationship between risk factors and hepatic histological changes in obese women. Methods A case-control design study. Women with NAFLD (cases) were compared with a control group of obese women without NAFLD matched by age, body mass index, waist circumference, and body fat. Irrespective of serum aminotransferases levels, diagnosis of NAFLD was established by the presence of type II diabetes, hypertriglyceridemia, and ultrasonographic changes of hepatic steatosis. Diagnosis of nonalcoholic steatohepatitis was performed by a liver biopsy. Women with an aspartate aminotransferase/alanine aminotransferase (ALT) ratio of at least 1 underwent liver biopsy. Alcohol consumption, hepatitis, and drugs that promote cholestasis or liver injury were the exclusion criteria. Multiple regression analysis was used to compute the association between the risk factors and NAFLD, and Spearman's analysis was used to examine its relationship with histological hepatic changes. Results A total of 108 obese women were enrolled. The frequency of high blood pressure, hypertriglyceridemia, and diabetes was similar between the groups. ALT (54.4 +/- 33.3 and 39.8 +/- 29.8, P= 0.03) but not aspartate aminotransferase (45.4 +/- 23.1 and 36.7 +/- 21.2, P= 0.06) was significantly higher in the women with NAFLD. The multivariate regression analysis showed a significant association of ALT (odds ratio 2.7; 95% confidence interval, 1.3-10.4), but not other variables with NAFLD. Type II diabetes was strongly correlated with ballooning and inflammation, and ALT with inflammation and fibrosis. Conclusion Obese women with similar metabolic alterations exhibit different hepatic outcomes. Elevation of ALT, but not other risk factors, was associated with NAFLD. Diabetes and ALT correlate with histological hepatic changes.
引用
收藏
页码:399 / 403
页数:5
相关论文
共 50 条
  • [21] Letter regarding "Risk factors in nonalcoholic fatty liver disease"
    Pratap, Abhijit
    More, Umesh
    Phalak, Pradnya
    Deshmukh, Anita
    CLINICAL AND MOLECULAR HEPATOLOGY, 2023, 29 (04) : 1046 - 1047
  • [22] Risk factors of nonalcoholic fatty liver disease in healthy women
    Guan, Hui
    Shao, Guangrui
    Cheng, Fang
    Ni, Pingjuan
    Wu, Mei
    MEDICINE, 2023, 102 (31) : E34437
  • [23] Epidemiology and risk factors of nonalcoholic fatty liver disease (NAFLD)
    Ajay Duseja
    Naga Chalasani
    Hepatology International, 2013, 7 : 755 - 764
  • [24] Epidemiology and risk factors of nonalcoholic fatty liver disease (NAFLD)
    Duseja, Ajay
    Chalasani, Naga
    HEPATOLOGY INTERNATIONAL, 2013, 7 : S755 - S764
  • [25] Questionnaire for risk factors of alcoholic and nonalcoholic fatty liver disease
    Szantova, Maria
    Skladany, Lubomir
    Janicko, Martin
    Oltman, Marian
    Drazilova, Sylvia
    Belovicova, Maria
    Zima, Martin
    Kupcova, Viera
    Adamcova-Selcanova, Svetlana
    Koller, Tomas
    Rac, Marek
    Jakabovicova, Martina
    Hlavata, Tereza
    Faktorova, Xenia
    Durkovicova, Zuzana
    Szamosova, Monika
    Jarcuska, Peter
    Mojto, Viliam
    Vorlickova, Maria
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2022, 123 (07): : 496 - 504
  • [26] Recent Epidemiology and Risk Factors of Nonalcoholic Fatty Liver Disease
    Huh, Youn
    Cho, Yoon Jeong
    Nam, Ga Eun
    JOURNAL OF OBESITY & METABOLIC SYNDROME, 2022, 31 (01) : 17 - 27
  • [27] Hepatic Innervations and Nonalcoholic Fatty Liver Disease
    Adori, Monika
    Bhat, Sadam
    Gramignoli, Roberto
    Valladolid-Acebes, Ismael
    Bengtsson, Tore
    Uhlen, Mathias
    Adori, Csaba
    SEMINARS IN LIVER DISEASE, 2023, 43 (02) : 149 - 162
  • [28] Hepatic iron and nonalcoholic fatty liver disease
    Younossi, ZM
    Gramlich, T
    Bacon, BR
    Matteoni, CA
    Boparai, N
    O'Neill, R
    McCullough, AJ
    HEPATOLOGY, 1999, 30 (04) : 847 - 850
  • [29] Quantitative Histological Assessment in Nonalcoholic Fatty Liver Disease
    Gawrieh, Samer
    Kleiner, David E.
    Chalasani, Naga
    Vanderbeck, Scott
    HEPATOLOGY, 2020, 72 (02) : 785 - 785
  • [30] Large-scale analysis of factors influencing nonalcoholic fatty liver disease and its relationship with liver enzymes
    Bi, W. R.
    Yang, C. Q.
    Shi, Q.
    Xu, Y.
    Cao, C. P.
    Ling, J.
    Wang, X. Y.
    GENETICS AND MOLECULAR RESEARCH, 2014, 13 (03): : 5880 - 5891